CQB Seminar- Dr. Ron Dror- Stanford University | March 21, 2025

Join the CQB on Friday, March 21, 2025 from 3-4:00 pm in Wilkinson 021 as we hear from our next guest speaker, Dr. Ron Dror, Professor of Computer Science at Sanford University as he will be discussing, ” Discovering Safe, Effective Drugs via Machine Learning and Simulation of 3D Structure.”

Bio: Ron Dror is the Cheriton Family Professor of Computer Science in the Stanford Artificial Intelligence Lab and a professor, by courtesy, of Structural Biology and of Molecular and Cellular Physiology at the Stanford School of Medicine. He leads a research group that uses molecular simulation and machine learning to elucidate biomolecular structure, dynamics, and function, and to guide the development of more effective medicines. He collaborates extensively with experimentalists in both academia and industry. Before moving to Stanford, he served as second-in-command of D. E. Shaw Research, a hundred-person company, having joined as its first hire. Dr. Dror earned a PhD in Electrical Engineering and Computer Science at MIT and an MPhil in Biological Sciences as a Churchill Scholar at the University of Cambridge.

 

Abstract: Recent years have seen dramatic advances in both experimental determination and computational prediction of macromolecular structures. These structures hold great promise for the discovery of highly effective drugs with minimal side effects, but structure-based design of such drugs remains challenging. I will describe recent progress toward this goal, using both atomic-level molecular simulations and machine learning on three-dimensional structures.

CQB Seminar- Rodrigo Reyes- McGill University

Our third guest speaker for this semester is Dr. Rodrigo Reyes. Dr. Reyes obtained his BSc in Biology from the National Autonomous University of Mexico, followed by an MSc at Concordia University (Montreal) under the supervision of Prof. Elaine Newman, where he studied bacterial cell division. He earned his PhD in Biochemistry from the University of Oxford (UK), working with Prof. David Sherratt studying DNA replication and chromosome segregation in bacteria. He subsequently held a Todd-Bird Junior Research Fellowship (New College, Oxford), allowing him to continue as a postdoctoral researcher for three additional years.

In 2013, Rodrigo joined the Department of Biology at McGill University, where he is currently an Associate Professor. His laboratory focuses on leveraging recent advancements in microscopy to uncover the mechanistic links between DNA replication and genome integrity. Central to his work is the use of live-cell single-molecule microscopy to characterize the dynamic activities of proteins involved in DNA replication, DNA repair and chromosome segregation in bacteria, budding yeast, and human cells.

Abstract: This seminar will explore two themes in cellular regulation and genome integrity. First, I will present findings from single-molecule microscopy studies that reveal the mechanisms and functional advantages of subunit turnover within the bacterial replisome, highlighting its critical role in maintaining genome stability. Second, I will discuss how dynamic interactions between transcription factors and chromatin serve as a sensor for cell size, orchestrating the start of the cell cycle in yeast. Together, these studies shed light on fundamental processes that safeguard genetic information and regulate cell division across domains of life.

CQB Seminar: Shriya Srinivasan, PhD- Harvard University

Join the CQB for our seminar series, featuring our second guest speaker of the semester: Dr. Shriya S. Srinivasan

Dr. Shriya Srinivasan is an assistant professor of bioengineering at Harvard University where she directs the Harvard Biohybrid Organs and Neuroprosthetics (BIONICS) lab. The lab focuses on the development of surgical reconstruction techniques in consort with bidirectional neural implants for improved sensorimotor control.

Shriya graduated from Case Western Reserve University with a BS in biomedical engineering, with a concentration in biomaterials. She then received her doctoral degree in medical engineering and medical physics through the Harvard-MIT Health Sciences and Technology program in January 2020. Her doctoral research focused on the development of novel neural interfaces utilizing tissue engineering to better interface human limbs with prostheses, in the context of amputation and paralysis. She developed the Regenerative Agonist-antagonist Myoneural Interface (AMI) that enables patients to control their prosthesis with native neural signals. She also explored optogenetic techniques to create novel strategies to accelerate and improve neural control.

As a junior fellow at the Harvard Society of Fellows and Schmidt Science Fellow, Shriya worked in the labs of Dr. Giovanni Traverso and Dr. Robert Langer, designing ingestible bioelectronics for gastrointestinal neuromodulation.

Shriya has been awarded the Delsys Prize, the Lemelson-MIT Student Prize for her innovative work, and recognized by Forbes and the MIT Technology Review as one of 30 innovators under 30.

Shriya was a former director of MIT Hacking Medicine, where she led educational and programmatic initiatives for design thinking education and medtech innovation – interfacing with various governmental and corporate entities. She also founded Project Prana, a nonprofit devoted to affordable medical technology innovation- which commercialized a ventilator multiplexer to market during the pandemic. In her spare time, Shriya performs Indian classical dance with the Anubhava Dance Company.

Abstract:

The gut-brain axis is an exciting frontier in science. This complex communication network influences everything from mood and cognition to immune responses, emphasizing our gut’s key role in overall health. For many, diseases like gastroparesis and ileus disrupt the normal digestive process, leading to debilitating symptoms and impacting quality of life. These conditions hamper the natural rhythm of the gut, affecting the body’s energy balance and comfort.

Innovative neural interfaces are reshaping treatment by seamlessly interacting with the gut’s nervous system. These devices use precise electrical and mechanostimulation to engage with specific neural pathways, restoring digestive movements and optimizing organ function. By stimulating the nerves of the GI tract, they can restart peristalsis and even simulate sensations like fullness to modulate hunger and satiety.  Explore the design of ingestible neural interfaces to sense, monitor, and treat the gut.

CQB Seminar- Maria Brbic, PhD- EPFL

Join the CQB for our seminar series, featuring our first guest speaker of the semester: Dr. Maria Brbic.

Maria Brbic (https://brbiclab.epfl.ch/) is an Assistant Professor of Computer Science and of Life Sciences at the Swiss Federal Institute of Technology, Lausanne (EPFL). She develops new machine learning methods and applies her methods to advance biology and biomedicine. Her methods have been used by global cell atlas consortia efforts aiming to create reference maps of all cell types with the potential to transform biomedicine, including the Human BioMolecular Atlas Program (HuBMAP) and Fly Cell Atlas consortium. Prior to joining the EPFL faculty in 2022, Maria was a  postdoctoral fellow at Stanford University, Department of Computer Science, and was a member of  the Chan Zuckerberg Biohub at Stanford. Maria received her Ph.D. from University of Zagreb in 2019 while also researching at Stanford University as a Fulbright Scholar and University of Tokyo. Among other awards and recognitions, she was named a Rising Star in EECS by MIT in 2021, she received the Early Career Bioinformatics Award by SIB in 2023 and she was awarded with the SNSF Starting Grant in 2024.

Abstract:

We are witnessing an AI revolution. At the heart of this revolution are generative AI models that, powered by advanced architectures and large datasets, are transforming AI across a variety of disciplines. But how can AI facilitate and eventually enable groundbreaking discoveries in life sciences? How can it bring us closer to understanding biology – the functions of our cells, their alterations in diseases, and variations across species? In the first part of the talk, I will present AI methods that build upon protein foundation models and enable us to learn cell representations across single-cell RNA-seq datasets from different species. Next, I will demonstrate how generative AI can uncover spatial relationships between cells, enabling the reassembly of tissues from dissociated single cells. Finally, I will discuss the future of discovery in the era of generative AI and foundation models, highlighting the paradigm shift in machine learning required to revolutionize biology.

CQB & DMI Special Seminar with Dr. Yongshae Shin- January 10, 2025

Join the CQB & DMI for a special seminar with Dr. Yongshae Shin. Dr. Shin is an Associate Professor in the Department of Mechanical Engineering at Seoul National University, and an Adjunct Professor in the Interdisciplinary Program in Bioengineering and Department of Biological Sciences. The focus of Prof. Shin’s group research is to understand and engineer self-organization processes in living systems. Of particular interest are biomolecular condensation, especially its biophysical mechanisms and physiological functions. For this, he combines multiple approaches including single-molecule resolution quantitative imaging, reconstitution of biomolecular condensates both in test tube and in cellulo, and optogenetic manipulation of biological phase separation. He received his BS in Mechanical and Aerospace Engineering from Seoul National University, and MS/PhD degrees in Mechanical Engineering from Massachusetts Institute of Technology. He then went on to Princeton University as a Postdoctoral Research Associate in the Department of Chemical and Biological Engineering. He was selected as the World Economic Forum Young Scientist in 2019.

 

Abstract: Biomolecular condensates represent a condensed state of living matter, widely observed in various cellular processes. Condensates are composed of a set of distinct molecular components, organizing diverse biochemical reactions. How condensate function emerges from the collective interactions of its components remains elusive. In this talk, I will discuss our ongoing efforts to study the biophysical basis of condensate-driven cellular functions. I will first introduce density as a key parameter that can impact condensate function. Using refractive-index imaging, we uncovered that intracellular condensates exhibit a broad range of density, where RNA plays a key regulatory role in lowering condensate density. I will then switch to the second topic probing the effect of RNA condensation on translation activity. Using optogenetic cellular reconstitution, we found that condensation itself provides suppressive microenvironments for mRNA translation, and solidifying condensates further inhibits translation activities. Our works highlight an intimate link between the physical properties of condensates and associated biochemical functions.

CQB Seminar- Dr. Jim Pfaendtner- NC State University

Join the CQB for our last seminar series of the Fall 2024 semester on Friday, December 6, 2024 from 3-4:00 pm in Wilkinson 021.  We will be hearing from our guest speaker, Dr. Jim Pfaendtner.

Jim Pfaendtner is the Louis Martin-Vega Dean of Engineering at NC State University. Previously, Pfaendtner served as chair of the Department of Chemical Engineering at the University of Washington. His research focuses on using computer simulations to understand molecular behavior for applications in biotechnology and advanced materials. Pfaendtner earned his B.S. in chemical engineering from Georgia Tech and his Ph.D. from Northwestern University.

Abstract:

Peptoids, or n-substitued glycines, are complex and diverse oligomeric structures which have been explored for a number of biomimetic applications including drug delivery, surfactants, and catalysts. In contrast to their peptide counterparts, on peptoids the sidechain is bonded to the backbone nitrogen resulting in a flexible omega backbone dihedral that is able to isomerize into both stable cis- and trans- backbone conformations. This unique feature of peptoids allows for these structures to potentially span a significantly larger configurational space of chemical and structural functionality through the careful tuning of their side chains. This vast chemical and structural space has created significant challenges for rational design of new structures and functions as the underlying molecular scale driving forces that give rise to sequence/structure/function relationships have proven difficult to uncover.

This talk will highlight recent developments from our group in the use of statistical mechanical tools to accelerate molecular simulations of rare events like peptoid folding, aggregation and adsorption on inorganic surfaces. The first part of the talk focuses on studies of peptoid folding. Peptoids can freely explore a 12-dimensional helical configurational space with stabilization dictated largely by interactions between sidechains. I will discuss the thermodynamic basis of helix stabilization by chiral sidechains as well as fundamental aspects of the simulation science and the role of solvent in folding. Implications for rational design of higher order (tertiary structures) will be discussed. The remainder of the talk focuses on the use of peptoids in biomineralization. We discuss the rational design of peptoid mimics of the well-known R5/silaffin system, compare their nanoscale properties with peptides, and highlight experimental findings showing the efficacy of peptoids in biomineralization applications as well as similarities and differences between the peptoid and peptide systems. If available time remains, I will briefly discuss our group’s use of machine learning models to assist in high throughput screening towards inverse design of new sequences that precisely tune surface adsorption energies for biomolecules.

CQB Seminar- Dr. Theresa M. Reineke- University of Minnesota

Join the Duke Center for Quantitative Biodesign on Friday, November 8, 2024 from 3-4:00 pm in Wilkinson 021 as we hear from our next guest speaker, Dr. Theresa M. Reineke.

Dr. Reineke is the Prager Endowed Chair in Macromolecular Science and a Distinguished McKnight University Professor in the Department of Chemistry at the University of Minnesota. She also holds graduate faculty appointments in the Departments of Chemical Engineering/Materials Science and Pharmaceutics. She received a B.S. Degree from the University of Wisconsin-Eau Claire, a M.S. Degree from Arizona State University, and a Ph.D. from the University of Michigan. She then received a National Institutes of Health Postdoctoral Research Fellowship for her work in gene therapy at the California Institute of Technology prior to beginning her independent faculty career.

Her research group is focused on enabling fundamental and applied technology advancements in the fields of macromolecules for nucleic acid delivery and gene editing, oral delivery of therapeutics, and sustainability. She has published over 200 peer-reviewed manuscripts and patents and manages a large group of researchers supported by several corporate, private and national funding agencies. Reineke is a Fellow of the American Chemical Society, Royal Society of Chemistry, along with the Kavli and Alfred P. Sloan Foundations. She has received numerous awards, including in the 2005 National Science Foundation CAREER and Beckman Foundation Young Investigator Awards, 2008 Camille and Henry Dreyfus Teacher-Scholar Award, 2009 National Institutes of Health Director’s New Innovator Award, 2012 Outstanding New Investigator Award from the American Society of Gene and Cell Therapy, 2017 Carl S. Marvel Creative Polymer Chemistry Award from the American Chemical Society Division of Polymer Chemistry, 2018 DuPont Nutrition and Health Sciences Excellence Medal, and 2022 Arthur C. Cope Scholar Award from the American Chemical Society. Reineke has also served for 11 years as an Associate Editor for the journals ACS MacroLetters and Chemical Science and in 2023 became Editor-in Chief of Bioconjugate Chemistry. Further, Reineke has cofounded three biotech companies in the field of nucleic acid delivery: Techulon, Inc., Nanite, Inc., and LiberateBio, Inc.

3rd Annual AI in Biodesign Symposium- October 16th-17th, 2024

This fall break, the Duke Center for Quantitative Biodesign (CQB) hosted our 3rd Annual Symposium, highlighting the innovative role of AI in Biodesign. A huge thank you to everyone who attended, and special thanks to our keynote speakers: Mary Dunlop (Boston University),  Kevin Yang (Microsoft for Startups, César de la Fuente, PhD (University of Pennsylvania), Philip Romero (Duke University Pratt School of Engineering) Caleb Bashor (Rice University Department of Bioengineering), Tom Sercu (EvolutionaryScale) , Matt Pavlovich (Trends in Biotechnology), & Rohit Singh ( Duke University School of Medicine) their incredible presentations.

We’d also like to congratulate our poster session winners:
First Place: Lauren Hong
Runner-Ups: Nathaniel Blalock and Jennifer Hennigan

A heartfelt thanks to the symposium committee for their help in organizing and facilitating such a successful event. We thoroughly enjoyed connecting with all of you and look forward to more exciting discussions and collaborations next year!

Dr. Alex Holehouse- October 4, 2024- Washington University School of Medicine in St. Louis

Join the Duke Center for Quantitative Biodesign on Friday, October 4, 2024 at 3:00 pm in Wilkinson 021. Our guest speaker, Dr. Alex Holehouse, is an Assistant Professor of Biochemistry and Molecular Biophysics at Washington University in St. Louis School of Medicine, where he will be discussing “Mapping from sequence to function in intrinsically disordered regions.”

The Holehouse Lab studies how biological function is encoded into intrinsically disordered proteins and how this goes wrong in disease. They use a combination of physics-based models, bioinformatics, deep learning, and quantitative cell biology.

Bio:  Alex received his Ph.D. Washington University in St. Louis, Computational Biophysics in 2017,  MsC. From Imperial College London, Computer Science in 2011, and his MBioch from University of Oxford, Molecular & Cellular Biochemistry in 2010.

Abstract:Intrinsically disordered protein regions (IDRs) are ubiquitous across all life kingdoms and play various essential cellular roles. Unlike folded domains, which are well-described by one or a small number of structurally similar states, IDRs exist in a collection of structurally distinct conformers known as an ensemble. While IDRs are ‘disordered’, they are not ‘unstructured’ – sequence-specific effects influence intra- and inter-molecular interactions that ultimately dictate biological function. Here, we will discuss recent advances that combine chemical physics, informatics, and deep learning to infer biologically important functions directly from sequence. These approaches offer opportunities for understanding IDR evolution, interpretation of disease-associated variants of unknown significance, and rationally designing functional IDRs with specific functional properties.

Dr. Hernan Garcia- UC Berkeley- September 27, 2024

Join the CQB on Friday, September 27, 2024 from 3-4pm in Wilkinson 021,  as we kick off our fall 2024 semester with our first guest speaker, Dr. Hernan Garcia, Associate Professor in the Departments of Molecular & Cell Biology and Physics at University of California, Berkeley.

Bio: Hernan G. Garcia is an Associate Professor in the Departments of Molecular & Cell Biology and of Physics at UC Berkeley. As a Physical Biologist, his research aims to uncover the quantitative and predictive principles dictating biological phenomena, with particular emphasis on embryonic development. Hernan is a co-author of the textbook Physical Biology of the Celland has directed several courses at institutions such as the Kavli Institute for Theoretial Physics at UC Santa Barbara, and the Marine Biological Laboratory in Woods Hole, MA.

Abstract: Over the last few decades we have largely identified the repressors and activators that shape gene expression patterns in developing embryos and that, in turn, dictate cellular fates. Yet, despite amassing this great reservoir of knowledge, we are still incapable of predicting how the number, placement and affinity of binding sites for these transcription factors in regulatory DNA dictate gene expression patterns in space and time. Achieving such predictive understanding calls for going beyond molecular parts lists and for obtaining the in vivo biochemical information necessary for fueling theoretical models of transcriptional regulation in developing animals.

In this talk, I will show how we are using physics as a “microscope” to uncover the molecular mechanisms by which activators and repressors dictate transcription in space and time in developing animals. Specifically, using novel quantitative tools that we have developed for precision measurements, I will show that most developmental genes are transcribed in stochastic bursts, and that many transcription factors regulate gene expression by modulating the frequency, duration, and/or amplitude of these bursts. We will then engage in an iterative dialogue between theoretical models and quantitative experiments aimed at revealing the mechanisms underlying this control of transcriptional bursting. Our results challenge the textbook picture of activator and repressor action based on stable protein-protein interactions and call for a description of transcriptional control that acknowledges that the nucleus is not a bag of well-mixed transcription factors. Most importantly, our work sets a path forward for reaching a predictive understanding of cellular decision making and demonstrates how a quantitative dialogue between theory and experiment can shed light on biological mechanisms beyond the reach of even the best super resolution microscopes.